Who is the CEO of Biotron Limited?

The CEO of Biotron Limited is Michelle Miller GCertAppFin,.

What industry does Biotron Limited belong to?

Biotron Limited operates in the Biotechnology industry within the Healthcare sector.

Where is Biotron Limited headquartered?

Biotron Limited is headquartered at 66 Hunter Street, Sydney, NSW, 2000, AU.

What is the IPO date of Biotron Limited?

Biotron Limited went public on January 23, 2001.

How many employees does Biotron Limited have?

Biotron Limited has approximately 4 full-time employees.

Biotron Limited

BIT.AX•ASX

Healthcare

Biotechnology

A$0.002

A$0.00(0.00%)

Biotron Limited (BIT.AX) Company Profile & Overview

Explore Biotron Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Biotron Limited (BIT.AX) Company Profile & Overview

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

SectorHealthcare

IndustryBiotechnology

CEOMichelle Miller GCertAppFin,

Contact Information

https://www.biotron.com.au

61 2 9300 3344

66 Hunter Street, Sydney, NSW, 2000

Company Facts

4 Employees

IPO DateJan 23, 2001

CountryAU

Actively Trading

Frequently Asked Questions

;